EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.13.12.13 | Amyotrophic Lateral Sclerosis |
26056941 |
A highly sensitive assay of IRE1 activity using the small luciferase NanoLuc: Evaluation of ALS-related genetic and pathological factors. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
4
4
1
0 |
| 1.13.12.13 | Amyotrophic Lateral Sclerosis |
27687581 |
SOD1 dimerization monitoring using a novel split NanoLuc, NanoBit. |
ongoing research
unassigned |
3
0 |
| 1.13.12.13 | Arthritis |
31252609 |
Bioluminescent Ross River Virus Allows Live Monitoring of Acute and Long-Term Alphaviral Infection by In Vivo Imaging. |
diagnostic usage
ongoing research
unassigned |
3
1
0 |
| 1.13.12.13 | Border Disease |
32143534 |
Development of a High-Throughput Serum Neutralization Test Using Recombinant Pestiviruses Possessing a Small Reporter Tag. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 1.13.12.13 | Brain Neoplasms |
26002233 |
Detection of Brain Tumors and Systemic Metastases Using NanoLuc and Fluc for Dual Reporter Imaging. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
3
2
0 |
| 1.13.12.13 | Breast Neoplasms |
30240618 |
Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 1.13.12.13 | Bronchitis |
32983065 |
Development of HiBiT-Tagged Recombinant Infectious Bronchitis Coronavirus for Efficient in vitro and in vivo Viral Quantification. |
ongoing research
unassigned |
2
0 |
| 1.13.12.13 | Carcinogenesis |
31431076 |
A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion. |
ongoing research
unassigned |
1
0 |
| 1.13.12.13 | Carcinoma, Hepatocellular |
26310603 |
Novel reporter system to monitor early stages of the hepatitis B virus life cycle. |
ongoing research
unassigned |
3
0 |
| 1.13.12.13 | Carcinoma, Hepatocellular |
34507064 |
Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cells. |
therapeutic application
unassigned |
1
0 |
